(19)
(11) EP 1 714 656 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
20.09.2017 Bulletin 2017/38

(45) Mention of the grant of the patent:
16.08.2017 Bulletin 2017/33

(21) Application number: 05709801.4

(22) Date of filing: 07.02.2005
(51) International Patent Classification (IPC): 
A61K 31/593(2006.01)
A61K 47/22(2006.01)
A61P 19/10(2006.01)
 A61K 47/44(2017.01)
A61K 9/48(2006.01)
(86) International application number:
PCT/JP2005/001749
(87) International publication number:
WO 2005/074943 (18.08.2005 Gazette 2005/33)

(54)

ED-71 PREPARATION

ED-71-PRÄPARAT

PREPARATION DE L'ED-71

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

(30) Priority: 06.02.2004 JP 2004030702

(43) Date of publication of application:
25.10.2006 Bulletin 2006/43

(73) Proprietor: CHUGAI SEIYAKU KABUSHIKI KAISHA
Tokyo, 115-8543 (JP)

(72) Inventors:
  • KATSUKI, Hisakazu
    Tokyo 1158543 (JP)
  • SHIBATA, Masaki
    Shizuoka 4128513 (JP)
  • MURAMATSU, Kazunori
    Tokyo 1158543 (JP)
  • MIZUTANI, Akihiko
    Tokyo 1158543 (JP)
  • YAMAUCHI, Tsuyoshi
    Shizuoka 4260041 (JP)
  • SUZUKI, Kouji
    Tokyo 1158543 (JP)

(74) Representative: Vossius & Partner Patentanwälte Rechtsanwälte mbB 
Siebertstrasse 3
81675 München
81675 München (DE)


(56) References cited: : 
WO-A1-01/90061
JP-A- 2 215 765
JP-A- 6 041 060
JP-A- 10 072 432
JP-A- 2002 505 668
US-B1- 6 448 421
 WO-A1-03/047595
JP-A- 5 004 925
JP-A- 6 087 750
JP-A- 63 107 929
US-A1- 2003 170 324
   
  • DATABASE WPI Week 197811 Thomson Scientific, London, GB; AN 1978-20658A XP002684023, & JP 53 012414 A (CHUGAI PHARM CO LTD) 3 February 1978 (1978-02-03)
 
Remarks:
The file contains technical information submitted after the application was filed and not included in this specification
 
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).